GlassScriptPhysician profile
Anjali Varde
NPI 1619956422
$2,488.89
in general payments reported to CMS, 2019-2025
23 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $540 · 2021: $293 · 2022: $438 · 2023: $558 · 2024: $94.42 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $841 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $841.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $469.62 | 2020-2023 | Mounjaro, Jardiance, Trulicity |
| Astrazeneca Pharmaceuticals LP | $294.23 | 2019-2023 | Farxiga |
| Glaxosmithkline, LLC. | $287.73 | 2019-2023 | Arexvy, Fluarix Quadrivalent, Shingrix |
| Amarin Pharma, INC. | $250.53 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $201.66 | 2019-2024 | Capvaxive, Gardasil 9, Gardasil |
| Pfizer INC. | $199.45 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $150.00 | 2025 | |
| Inspire Medical Systems, INC. | $122.54 | 2025 | Inspire |
| Novo Nordisk INC | $106.76 | 2020-2022 | |
| Zealand Pharma US, INC. | $102.42 | 2022 | |
| Sanofi Pasteur INC. | $43.56 | 2023 | |
| Corcept Therapeutics | $36.82 | 2025 | Korlym |
| Astellas Pharma US INC | $30.50 | 2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $30.10 | 2025 | Aptima, Thinprep 2000 Processor |
| Genentech USA, INC. | $24.99 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $20.80 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.30 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.27 | 2021 | |
| Dermira, INC. | $17.27 | 2020 | |
| Seqirus USA INC | $17.25 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Abbvie INC. | $15.25 | 2021 | |
| Avanir Pharmaceuticals, INC. | $14.29 | 2021 | |
| Idorsia Pharmaceuticals US INC | $13.55 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anjali Varde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.